Anbio Biotechnology (NASDAQ:NNNN) Sets New 52-Week Low – Should You Sell?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $7.08 and last traded at $8.48, with a volume of 1287768 shares changing hands. The stock had previously closed at $8.74.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

Anbio Biotechnology Trading Down 3.0%

The stock’s 50-day simple moving average is $12.06 and its 200-day simple moving average is $21.04.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.